Results Peroral d-allulose suppresses food intake without aversion Peroral (p.o.) administration of d-allulose (Allu) at 1 and 3 g kg 1 , but not 0.3 g kg 1 , into the stomach using a stainless feeding needle decreased cumulative food intake for 0.5, 1, 2, 3, and 6 h after injection in C57BL/6J mice fasted overnight (16 h) (Fig
GLP-1 stands for glucagon-like-peptide 1 agonists, which regulate appetite by increasing naturally occurring hormones called incretins, making people feel full longer
Long-term chronic mold exposure has been associated with persistent immune dysregulation, hepatic and renal stress, and degenerative inflammatory patterns
& le Roux, C
These factors may contribute to PD development (34)
References to biological effects are provided for scientific context only and must not be interpreted as claims of therapeutic, diagnostic, or clinical benefit